Share Price and Basic Stock Data
Last Updated: November 10, 2025, 8:00 pm
| PEG Ratio | 2.19 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
3M India Ltd operates in the diversified sector, with a current market capitalization of ₹33,297 Cr and a share price of ₹29,545. The company has demonstrated a robust upward trajectory in its revenue, with the trailing twelve months (TTM) sales reported at ₹4,186 Cr, up from ₹3,959 Cr in the previous fiscal year. Quarterly sales figures reveal consistent growth, with the latest quarter (Jun 2024) recording ₹1,047 Cr, contributing to a year-on-year increase. Notably, the company’s sales rose from ₹744 Cr in Jun 2021 to ₹1,050 Cr in Jun 2023, showcasing a significant compound annual growth rate (CAGR). This growth can be attributed to its diverse product offerings and strong market presence, positioning it favorably against industry norms. Overall, 3M India Ltd’s revenue trends reflect a strong operational performance that aligns well with its strategic initiatives and market demand.
Profitability and Efficiency Metrics
3M India Ltd reported a net profit of ₹611 Cr for the TTM, translating to an impressive net profit margin of 13.92%. The company’s operating profit margin (OPM) stood at 19.98%, indicating strong operational efficiency. Comparative analysis reveals that the OPM has seen an upward trend, rising from 6% in Jun 2021 to 20% in Mar 2024. The return on equity (ROE) at 30.5% and return on capital employed (ROCE) at 40.5% further underscore the company’s effective capital utilization and profitability. Despite a relatively high price-to-earnings (P/E) ratio of 54.5, reflecting investor confidence in future earnings, the interest coverage ratio of 260.33x highlights the company’s ability to comfortably meet its interest obligations. These profitability metrics indicate strong operational leverage and financial health, positioning 3M India Ltd favorably for sustained growth.
Balance Sheet Strength and Financial Ratios
3M India Ltd’s balance sheet exhibits strong fundamentals, with total assets reported at ₹3,248 Cr and total liabilities at ₹1,165 Cr, showcasing a healthy asset-to-liability ratio. Reserves have increased to ₹2,136 Cr, providing a buffer for future investments and growth initiatives. The company has minimal borrowings of ₹18 Cr, indicating low financial leverage and a conservative approach to debt management. The book value per share stood at ₹1,905.80, significantly higher than the current market price, suggesting potential undervaluation. Furthermore, the company’s current and quick ratios of 2.52x and 2.02x, respectively, reflect strong liquidity positions. Overall, 3M India Ltd’s balance sheet strength and financial ratios suggest a solid foundation for future expansion while maintaining financial stability.
Shareholding Pattern and Investor Confidence
3M India Ltd’s shareholding pattern reveals a strong promoter holding of 75%, indicating significant management commitment to the company’s long-term vision. Foreign institutional investors (FIIs) hold 3.84%, while domestic institutional investors (DIIs) account for 8.10%, reflecting moderate institutional interest. The public shareholding stands at 13.05%, with a total of 34,588 shareholders, indicating a broad base of retail investors. The stability in promoter holdings and the slight fluctuations in institutional holdings suggest a relatively stable investor sentiment. However, the decline in FIIs from 4.26% in Sep 2022 to 3.56% in Sep 2023 raises a concern about potential foreign investor confidence. Overall, the shareholding structure demonstrates a solid foundation of support, although the dynamics of institutional investments warrant monitoring.
Outlook, Risks, and Final Insight
The outlook for 3M India Ltd appears positive, bolstered by consistent revenue growth and strong profitability metrics. However, potential risks include the high P/E ratio, which may limit future price appreciation unless earnings continue to grow significantly. Additionally, fluctuations in institutional investor confidence, particularly among FIIs, could impact stock performance. The company’s low debt levels provide a cushion against market volatility, but reliance on domestic markets could pose risks in the event of economic downturns. In conclusion, 3M India Ltd is well-positioned for growth, supported by a robust operational framework and strong financial health. However, stakeholders should remain vigilant regarding market trends and institutional investment patterns to navigate potential challenges effectively.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of 3M India Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| NESCO Ltd | 9,360 Cr. | 1,328 | 1,639/842 | 22.6 | 373 | 0.49 % | 21.1 % | 15.8 % | 2.00 |
| DCM Shriram Ltd | 19,442 Cr. | 1,246 | 1,502/903 | 27.3 | 463 | 0.72 % | 11.4 % | 8.66 % | 2.00 |
| Balmer Lawrie & Company Ltd | 3,302 Cr. | 193 | 246/147 | 12.4 | 114 | 4.40 % | 14.8 % | 14.0 % | 10.0 |
| 3M India Ltd | 40,563 Cr. | 36,025 | 37,000/25,714 | 66.4 | 1,906 | 0.44 % | 40.5 % | 30.5 % | 10.0 |
| Industry Average | 18,166.75 Cr | 9,698.00 | 32.18 | 714.00 | 1.51% | 21.95% | 17.24% | 6.00 |
Quarterly Result
| Metric | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 744 | 840 | 826 | 926 | 944 | 977 | 993 | 1,046 | 1,050 | 1,040 | 1,006 | 1,095 | 1,047 |
| Expenses | 696 | 748 | 731 | 768 | 827 | 854 | 822 | 852 | 877 | 847 | 827 | 880 | 841 |
| Operating Profit | 48 | 92 | 95 | 158 | 116 | 123 | 171 | 194 | 173 | 192 | 179 | 214 | 205 |
| OPM % | 6% | 11% | 12% | 17% | 12% | 13% | 17% | 19% | 16% | 18% | 18% | 20% | 20% |
| Other Income | 8 | 8 | 8 | 9 | 11 | 35 | 12 | 10 | 15 | 17 | 17 | 30 | 22 |
| Interest | 1 | 1 | 0 | 2 | 1 | 0 | 1 | 6 | 1 | 1 | 1 | 1 | 3 |
| Depreciation | 15 | 13 | 14 | 13 | 14 | 15 | 15 | 14 | 14 | 13 | 13 | 13 | 14 |
| Profit before tax | 41 | 87 | 89 | 151 | 113 | 143 | 167 | 184 | 173 | 196 | 181 | 231 | 211 |
| Tax % | 26% | 26% | 25% | 27% | 26% | 26% | 25% | 26% | 25% | 25% | 25% | 25% | 26% |
| Net Profit | 30 | 64 | 67 | 111 | 84 | 106 | 125 | 136 | 129 | 146 | 135 | 173 | 157 |
| EPS in Rs | 26.72 | 57.01 | 59.24 | 98.46 | 74.80 | 94.30 | 110.79 | 120.48 | 114.70 | 129.70 | 120.05 | 153.44 | 139.50 |
Last Updated: Unknown
Below is a detailed analysis of the quarterly data for 3M India Ltd based on the most recent figures (Jun 2024) and their trends compared to the previous period:
- For Sales, as of Jun 2024, the value is 1,047.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,095.00 Cr. (Mar 2024) to 1,047.00 Cr., marking a decrease of 48.00 Cr..
- For Expenses, as of Jun 2024, the value is 841.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 880.00 Cr. (Mar 2024) to 841.00 Cr., marking a decrease of 39.00 Cr..
- For Operating Profit, as of Jun 2024, the value is 205.00 Cr.. The value appears to be declining and may need further review. It has decreased from 214.00 Cr. (Mar 2024) to 205.00 Cr., marking a decrease of 9.00 Cr..
- For OPM %, as of Jun 2024, the value is 20.00%. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 20.00%.
- For Other Income, as of Jun 2024, the value is 22.00 Cr.. The value appears to be declining and may need further review. It has decreased from 30.00 Cr. (Mar 2024) to 22.00 Cr., marking a decrease of 8.00 Cr..
- For Interest, as of Jun 2024, the value is 3.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.00 Cr. (Mar 2024) to 3.00 Cr., marking an increase of 2.00 Cr..
- For Depreciation, as of Jun 2024, the value is 14.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 13.00 Cr. (Mar 2024) to 14.00 Cr., marking an increase of 1.00 Cr..
- For Profit before tax, as of Jun 2024, the value is 211.00 Cr.. The value appears to be declining and may need further review. It has decreased from 231.00 Cr. (Mar 2024) to 211.00 Cr., marking a decrease of 20.00 Cr..
- For Tax %, as of Jun 2024, the value is 26.00%. The value appears to be increasing, which may not be favorable. It has increased from 25.00% (Mar 2024) to 26.00%, marking an increase of 1.00%.
- For Net Profit, as of Jun 2024, the value is 157.00 Cr.. The value appears to be declining and may need further review. It has decreased from 173.00 Cr. (Mar 2024) to 157.00 Cr., marking a decrease of 16.00 Cr..
- For EPS in Rs, as of Jun 2024, the value is 139.50. The value appears to be declining and may need further review. It has decreased from 153.44 (Mar 2024) to 139.50, marking a decrease of 13.94.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 26, 2024, 2:43 pm
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 2,710 | 3,017 | 2,987 | 2,605 | 3,336 | 3,959 | 4,189 | 4,186 |
| Expenses | 2,211 | 2,481 | 2,537 | 2,345 | 2,947 | 3,355 | 3,430 | 3,396 |
| Operating Profit | 499 | 536 | 450 | 259 | 389 | 604 | 759 | 791 |
| OPM % | 18% | 18% | 15% | 10% | 12% | 15% | 18% | 19% |
| Other Income | 55 | 60 | 46 | 25 | 37 | 68 | 78 | 86 |
| Interest | 2 | 1 | 4 | 2 | 4 | 7 | 3 | 5 |
| Depreciation | 44 | 44 | 59 | 62 | 55 | 58 | 53 | 53 |
| Profit before tax | 508 | 551 | 433 | 220 | 368 | 607 | 781 | 819 |
| Tax % | 34% | 33% | 26% | 26% | 26% | 26% | 25% | |
| Net Profit | 333 | 366 | 322 | 162 | 272 | 451 | 583 | 611 |
| EPS in Rs | 295.91 | 325.06 | 285.99 | 144.14 | 241.43 | 400.37 | 517.90 | 542.69 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 237% | 132% |
YoY Net Profit Growth
| Year | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 |
|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 9.91% | -12.02% | -49.69% | 67.90% | 65.81% | 29.27% |
| Change in YoY Net Profit Growth (%) | 0.00% | -21.93% | -37.67% | 117.59% | -2.09% | -36.54% |
3M India Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 6 years from 2018-2019 to 2023-2024.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 7% |
| 3 Years: | 17% |
| TTM: | 3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 10% |
| 3 Years: | 53% |
| TTM: | 23% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 9% |
| 3 Years: | 9% |
| 1 Year: | -13% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 19% |
| 3 Years: | 22% |
| Last Year: | 30% |
Last Updated: September 4, 2025, 9:35 pm
Balance Sheet
Last Updated: November 9, 2025, 1:31 pm
| Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|
| Equity Capital | 11 | 11 | 11 | 11 | 11 | 11 | 11 |
| Reserves | 1,055 | 1,422 | 1,740 | 1,899 | 2,172 | 1,666 | 2,136 |
| Borrowings | 10 | 14 | 42 | 23 | 25 | 27 | 18 |
| Other Liabilities | 1,234 | 672 | 578 | 718 | 798 | 1,010 | 1,083 |
| Total Liabilities | 2,311 | 2,118 | 2,371 | 2,652 | 3,006 | 2,714 | 3,248 |
| Fixed Assets | 303 | 286 | 306 | 266 | 307 | 338 | 332 |
| CWIP | 6 | 12 | 7 | 24 | 23 | 25 | 12 |
| Investments | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Other Assets | 2,001 | 1,820 | 2,058 | 2,362 | 2,676 | 2,352 | 2,903 |
| Total Assets | 2,311 | 2,118 | 2,371 | 2,652 | 3,006 | 2,714 | 3,248 |
Below is a detailed analysis of the balance sheet data for 3M India Ltd based on the most recent figures (Mar 2024) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2024, the value is 11.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2023) which recorded 11.00 Cr..
- For Reserves, as of Mar 2024, the value is 2,136.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,666.00 Cr. (Mar 2023) to 2,136.00 Cr., marking an increase of 470.00 Cr..
- For Borrowings, as of Mar 2024, the value is 18.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 27.00 Cr. (Mar 2023) to 18.00 Cr., marking a decrease of 9.00 Cr..
- For Other Liabilities, as of Mar 2024, the value is 1,083.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,010.00 Cr. (Mar 2023) to 1,083.00 Cr., marking an increase of 73.00 Cr..
- For Total Liabilities, as of Mar 2024, the value is 3,248.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,714.00 Cr. (Mar 2023) to 3,248.00 Cr., marking an increase of 534.00 Cr..
- For Fixed Assets, as of Mar 2024, the value is 332.00 Cr.. The value appears to be declining and may need further review. It has decreased from 338.00 Cr. (Mar 2023) to 332.00 Cr., marking a decrease of 6.00 Cr..
- For CWIP, as of Mar 2024, the value is 12.00 Cr.. The value appears to be declining and may need further review. It has decreased from 25.00 Cr. (Mar 2023) to 12.00 Cr., marking a decrease of 13.00 Cr..
- For Investments, as of Mar 2024, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2023) which recorded 0.00 Cr..
- For Other Assets, as of Mar 2024, the value is 2,903.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,352.00 Cr. (Mar 2023) to 2,903.00 Cr., marking an increase of 551.00 Cr..
- For Total Assets, as of Mar 2024, the value is 3,248.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,714.00 Cr. (Mar 2023) to 3,248.00 Cr., marking an increase of 534.00 Cr..
Notably, the Reserves (2,136.00 Cr.) exceed the Borrowings (18.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|
| Free Cash Flow | 489.00 | 522.00 | 408.00 | 236.00 | 364.00 | 577.00 | 741.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|
| Debtor Days | 77 | 71 | 65 | 68 | 58 | 59 | 61 |
| Inventory Days | 96 | 94 | 92 | 104 | 85 | 91 | 77 |
| Days Payable | 93 | 81 | 66 | 114 | 94 | 113 | 120 |
| Cash Conversion Cycle | 79 | 84 | 92 | 58 | 49 | 36 | 19 |
| Working Capital Days | -26 | 54 | 63 | 54 | 38 | 32 | 22 |
| ROCE % | 44% | 27% | 12% | 18% | 31% | 41% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| UTI Flexi Cap Fund | 64,500 | 0.7 | 183.83 | 78,812 | 2025-08-14 13:03:48 | -18.16% |
| Axis Midcap Fund | 54,955 | 0.49 | 156.62 | 77,057 | 2025-08-14 13:03:48 | -28.68% |
| Bandhan Core Equity Fund | 48,179 | 1.41 | 137.31 | N/A | N/A | N/A |
| UTI MNC Fund | 27,924 | 2.78 | 79.58 | N/A | N/A | N/A |
| ICICI Prudential Smallcap Fund | 11,535 | 0.38 | 32.87 | N/A | N/A | N/A |
| UTI Infrastructure Fund | 7,921 | 0.99 | 22.57 | N/A | N/A | N/A |
| UTI Unit Linked Insurance Plan (ULIP) - Fifteen Year Plan | 5,625 | 0.29 | 16.03 | N/A | N/A | N/A |
| UTI Unit Linked Insurance Plan (ULIP) - Ten Year Plan | 5,625 | 0.29 | 16.03 | N/A | N/A | N/A |
| Bandhan Infrastructure Fund | 5,215 | 0.85 | 14.86 | N/A | N/A | N/A |
| Bandhan Multi Cap Fund | 4,500 | 0.47 | 12.83 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 517.90 | 400.37 | 241.43 | 144.14 | 285.99 |
| Diluted EPS (Rs.) | 517.90 | 400.37 | 241.43 | 144.14 | 285.99 |
| Cash EPS (Rs.) | 564.89 | 451.57 | 290.36 | 199.04 | 338.66 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 1905.80 | 1489.09 | 1938.35 | 1695.79 | 1554.24 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 1905.80 | 1489.09 | 1938.35 | 1695.79 | 1554.24 |
| Revenue From Operations / Share (Rs.) | 3718.89 | 3514.72 | 2961.22 | 2312.30 | 2651.15 |
| PBDIT / Share (Rs.) | 743.33 | 596.88 | 378.47 | 252.30 | 439.91 |
| PBIT / Share (Rs.) | 696.34 | 545.67 | 329.55 | 197.40 | 387.24 |
| PBT / Share (Rs.) | 693.48 | 539.22 | 326.24 | 195.22 | 383.99 |
| Net Profit / Share (Rs.) | 517.90 | 400.37 | 241.43 | 144.14 | 285.99 |
| NP After MI And SOA / Share (Rs.) | 517.90 | 400.37 | 241.43 | 144.14 | 285.99 |
| PBDIT Margin (%) | 19.98 | 16.98 | 12.78 | 10.91 | 16.59 |
| PBIT Margin (%) | 18.72 | 15.52 | 11.12 | 8.53 | 14.60 |
| PBT Margin (%) | 18.64 | 15.34 | 11.01 | 8.44 | 14.48 |
| Net Profit Margin (%) | 13.92 | 11.39 | 8.15 | 6.23 | 10.78 |
| NP After MI And SOA Margin (%) | 13.92 | 11.39 | 8.15 | 6.23 | 10.78 |
| Return on Networth / Equity (%) | 27.17 | 26.88 | 12.45 | 8.49 | 18.40 |
| Return on Capital Employeed (%) | 35.83 | 35.44 | 16.53 | 11.32 | 24.23 |
| Return On Assets (%) | 17.96 | 16.61 | 9.04 | 6.12 | 13.58 |
| Asset Turnover Ratio (%) | 1.41 | 1.26 | 1.04 | 0.91 | 1.16 |
| Current Ratio (X) | 2.52 | 2.17 | 3.20 | 3.10 | 3.27 |
| Quick Ratio (X) | 2.02 | 1.55 | 2.56 | 2.44 | 2.50 |
| Inventory Turnover Ratio (X) | 2.80 | 2.96 | 2.86 | 2.16 | 2.50 |
| Dividend Payout Ratio (NP) (%) | 19.30 | 212.30 | 0.00 | 0.00 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 17.70 | 188.23 | 0.00 | 0.00 | 0.00 |
| Earning Retention Ratio (%) | 80.70 | -112.30 | 0.00 | 0.00 | 0.00 |
| Cash Earning Retention Ratio (%) | 82.30 | -88.23 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 260.33 | 92.48 | 114.60 | 115.82 | 135.32 |
| Interest Coverage Ratio (Post Tax) (X) | 182.38 | 63.04 | 74.10 | 67.17 | 88.97 |
| Enterprise Value (Cr.) | 33848.64 | 25120.84 | 20825.74 | 33001.61 | 20527.25 |
| EV / Net Operating Revenue (X) | 8.08 | 6.34 | 6.24 | 12.67 | 6.87 |
| EV / EBITDA (X) | 40.42 | 37.36 | 48.85 | 116.11 | 41.42 |
| MarketCap / Net Operating Revenue (X) | 8.40 | 6.55 | 6.64 | 13.08 | 7.13 |
| Retention Ratios (%) | 80.69 | -112.30 | 0.00 | 0.00 | 0.00 |
| Price / BV (X) | 16.40 | 15.45 | 10.15 | 17.83 | 12.17 |
| Price / Net Operating Revenue (X) | 8.40 | 6.55 | 6.64 | 13.08 | 7.13 |
| EarningsYield | 0.01 | 0.01 | 0.01 | 0.00 | 0.01 |
After reviewing the key financial ratios for 3M India Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 24, the value is 517.90. This value is within the healthy range. It has increased from 400.37 (Mar 23) to 517.90, marking an increase of 117.53.
- For Diluted EPS (Rs.), as of Mar 24, the value is 517.90. This value is within the healthy range. It has increased from 400.37 (Mar 23) to 517.90, marking an increase of 117.53.
- For Cash EPS (Rs.), as of Mar 24, the value is 564.89. This value is within the healthy range. It has increased from 451.57 (Mar 23) to 564.89, marking an increase of 113.32.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 1,905.80. It has increased from 1,489.09 (Mar 23) to 1,905.80, marking an increase of 416.71.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 1,905.80. It has increased from 1,489.09 (Mar 23) to 1,905.80, marking an increase of 416.71.
- For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 3,718.89. It has increased from 3,514.72 (Mar 23) to 3,718.89, marking an increase of 204.17.
- For PBDIT / Share (Rs.), as of Mar 24, the value is 743.33. This value is within the healthy range. It has increased from 596.88 (Mar 23) to 743.33, marking an increase of 146.45.
- For PBIT / Share (Rs.), as of Mar 24, the value is 696.34. This value is within the healthy range. It has increased from 545.67 (Mar 23) to 696.34, marking an increase of 150.67.
- For PBT / Share (Rs.), as of Mar 24, the value is 693.48. This value is within the healthy range. It has increased from 539.22 (Mar 23) to 693.48, marking an increase of 154.26.
- For Net Profit / Share (Rs.), as of Mar 24, the value is 517.90. This value is within the healthy range. It has increased from 400.37 (Mar 23) to 517.90, marking an increase of 117.53.
- For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 517.90. This value is within the healthy range. It has increased from 400.37 (Mar 23) to 517.90, marking an increase of 117.53.
- For PBDIT Margin (%), as of Mar 24, the value is 19.98. This value is within the healthy range. It has increased from 16.98 (Mar 23) to 19.98, marking an increase of 3.00.
- For PBIT Margin (%), as of Mar 24, the value is 18.72. This value is within the healthy range. It has increased from 15.52 (Mar 23) to 18.72, marking an increase of 3.20.
- For PBT Margin (%), as of Mar 24, the value is 18.64. This value is within the healthy range. It has increased from 15.34 (Mar 23) to 18.64, marking an increase of 3.30.
- For Net Profit Margin (%), as of Mar 24, the value is 13.92. This value exceeds the healthy maximum of 10. It has increased from 11.39 (Mar 23) to 13.92, marking an increase of 2.53.
- For NP After MI And SOA Margin (%), as of Mar 24, the value is 13.92. This value is within the healthy range. It has increased from 11.39 (Mar 23) to 13.92, marking an increase of 2.53.
- For Return on Networth / Equity (%), as of Mar 24, the value is 27.17. This value is within the healthy range. It has increased from 26.88 (Mar 23) to 27.17, marking an increase of 0.29.
- For Return on Capital Employeed (%), as of Mar 24, the value is 35.83. This value is within the healthy range. It has increased from 35.44 (Mar 23) to 35.83, marking an increase of 0.39.
- For Return On Assets (%), as of Mar 24, the value is 17.96. This value is within the healthy range. It has increased from 16.61 (Mar 23) to 17.96, marking an increase of 1.35.
- For Asset Turnover Ratio (%), as of Mar 24, the value is 1.41. It has increased from 1.26 (Mar 23) to 1.41, marking an increase of 0.15.
- For Current Ratio (X), as of Mar 24, the value is 2.52. This value is within the healthy range. It has increased from 2.17 (Mar 23) to 2.52, marking an increase of 0.35.
- For Quick Ratio (X), as of Mar 24, the value is 2.02. This value exceeds the healthy maximum of 2. It has increased from 1.55 (Mar 23) to 2.02, marking an increase of 0.47.
- For Inventory Turnover Ratio (X), as of Mar 24, the value is 2.80. This value is below the healthy minimum of 4. It has decreased from 2.96 (Mar 23) to 2.80, marking a decrease of 0.16.
- For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 19.30. This value is below the healthy minimum of 20. It has decreased from 212.30 (Mar 23) to 19.30, marking a decrease of 193.00.
- For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 17.70. This value is below the healthy minimum of 20. It has decreased from 188.23 (Mar 23) to 17.70, marking a decrease of 170.53.
- For Earning Retention Ratio (%), as of Mar 24, the value is 80.70. This value exceeds the healthy maximum of 70. It has increased from -112.30 (Mar 23) to 80.70, marking an increase of 193.00.
- For Cash Earning Retention Ratio (%), as of Mar 24, the value is 82.30. This value exceeds the healthy maximum of 70. It has increased from -88.23 (Mar 23) to 82.30, marking an increase of 170.53.
- For Interest Coverage Ratio (X), as of Mar 24, the value is 260.33. This value is within the healthy range. It has increased from 92.48 (Mar 23) to 260.33, marking an increase of 167.85.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 182.38. This value is within the healthy range. It has increased from 63.04 (Mar 23) to 182.38, marking an increase of 119.34.
- For Enterprise Value (Cr.), as of Mar 24, the value is 33,848.64. It has increased from 25,120.84 (Mar 23) to 33,848.64, marking an increase of 8,727.80.
- For EV / Net Operating Revenue (X), as of Mar 24, the value is 8.08. This value exceeds the healthy maximum of 3. It has increased from 6.34 (Mar 23) to 8.08, marking an increase of 1.74.
- For EV / EBITDA (X), as of Mar 24, the value is 40.42. This value exceeds the healthy maximum of 15. It has increased from 37.36 (Mar 23) to 40.42, marking an increase of 3.06.
- For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 8.40. This value exceeds the healthy maximum of 3. It has increased from 6.55 (Mar 23) to 8.40, marking an increase of 1.85.
- For Retention Ratios (%), as of Mar 24, the value is 80.69. This value exceeds the healthy maximum of 70. It has increased from -112.30 (Mar 23) to 80.69, marking an increase of 192.99.
- For Price / BV (X), as of Mar 24, the value is 16.40. This value exceeds the healthy maximum of 3. It has increased from 15.45 (Mar 23) to 16.40, marking an increase of 0.95.
- For Price / Net Operating Revenue (X), as of Mar 24, the value is 8.40. This value exceeds the healthy maximum of 3. It has increased from 6.55 (Mar 23) to 8.40, marking an increase of 1.85.
- For EarningsYield, as of Mar 24, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 23) which recorded 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in 3M India Ltd:
- Net Profit Margin: 13.92%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 35.83% (Industry Average ROCE: 21.95%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 27.17% (Industry Average ROE: 17.24%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 182.38
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.02
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 66.4 (Industry average Stock P/E: 32.18)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 13.92%
FAQ
What is the intrinsic value of 3M India Ltd?
3M India Ltd's intrinsic value (as of 10 November 2025) is 31016.12 which is 13.90% lower the current market price of 36,025.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 40,563 Cr. market cap, FY2025-2026 high/low of 37,000/25,714, reserves of ₹2,136 Cr, and liabilities of 3,248 Cr.
What is the Market Cap of 3M India Ltd?
The Market Cap of 3M India Ltd is 40,563 Cr..
What is the current Stock Price of 3M India Ltd as on 10 November 2025?
The current stock price of 3M India Ltd as on 10 November 2025 is 36,025.
What is the High / Low of 3M India Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of 3M India Ltd stocks is 37,000/25,714.
What is the Stock P/E of 3M India Ltd?
The Stock P/E of 3M India Ltd is 66.4.
What is the Book Value of 3M India Ltd?
The Book Value of 3M India Ltd is 1,906.
What is the Dividend Yield of 3M India Ltd?
The Dividend Yield of 3M India Ltd is 0.44 %.
What is the ROCE of 3M India Ltd?
The ROCE of 3M India Ltd is 40.5 %.
What is the ROE of 3M India Ltd?
The ROE of 3M India Ltd is 30.5 %.
What is the Face Value of 3M India Ltd?
The Face Value of 3M India Ltd is 10.0.